Trial intelligence / Profile preview

Autologous PBSC Transplant for Acute Leukemias

NCT00002567Phase 2Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Mar 1994
Primary completion
Nov 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of etoposide in acute leukemia, sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 1994; status: completed.

02

Drugs

etoposide
03

Conditions

acute leukemia

Beyond the preview

Go deeper on NCT00002567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call